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Abstract
Tissue inhibitors of metalloproteinases (TIMPs) regulate extracellular matrix (ECM) degradation by matrix metalloproteinases (MMPs).
We have examined the role of TIMP-3 on ECM homeostasis and bronchiole branching morphogenesis during murine embryogenesis.
Employing an in vitro organ culture system, we found decreased bronchiolar branching in null lungs when compared with wild type (WT)
counterparts after 2 days in culture. When a synthetic inhibitor of MMPs at low dose was added to the culture system, branching was
augmented regardless of genotype. Gelatin and in situ zymography revealed that null lungs exhibited enhanced activation of MMPs
throughout lung development. We analysed the impact of increased MMP activity on a number of ECM molecules by Western blot analysis,
but found that only fibronectin abundance was consistently reduced in the null lungs throughout development. To confirm that our observed
defect in culture was not simply a developmental delay in the null lung, we examined null and WT lungs from newborn pups. Here, we found
not only a reduced number of bronchioles in the null, but also that the bronchiole tubes were dilated compared with controls and that
alveologenesis was attenuated. We propose that the deletion of TIMP-3 disrupts the exquisite TIMP/MMP balance required for proper focal
ECM proteolysis, which leads to correct bronchiole branching morphogenesis in the developing mouse lung.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
The mouse lung originates on embryonic day 9.5 (Ed9.5)
as paired endodermal buds from the primitive foregut in-
vade into surrounding mesoderm. The epithelium develops
into the airways, while the mesoderm becomes the lung
stroma. Between Ed9.5 and Ed15.5 there is rapid growth
and branching of the primitive lung epithelium to form the
bronchiole pattern of the lung (Ten Have-Opbroek, 1991).
This branching morphogenesis results from a repetitive se-
ries of epithelial cleft and bud formation, and is dependent
on the surrounding mesenchyme and the basement mem-
brane (BM) that separates the two compartments. Elegant
grafting experiments demonstrated that distal mesenchyme,
when grafted next to denuded tracheal epithelium, could
induce multiple branches from a supernumerary tracheal
bud. Thus, the mesenchyme has an inductive action upon an
epithelium which would not normally bud and branch
(Alescio and Cassini, 1962).
Several lines of evidence suggest that remodeling of the
BM has an active role in the induction of branching. For
example, the BM separating epithelial and mesenchymal
cells at the tips of actively budding regions becomes rela-
tively thin with reduced amounts of nidogen, collagen IV,
fibronectin, and laminin-1 (Mollard and Dziadek, 1998).
Specific domains of the laminin-1 molecule may be in-
volved in eliciting a branch outgrowth by facilitating cell
attachment and consequently cell proliferation since neu-
tralizing anti-laminin antibodies inhibit branching in lung
organ culture (Schuger et al., 1991). Fibronectin, an extra-
cellular matrix (ECM) molecule found predominantly in the
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clefts of the developing lung (Roman et al., 1997), is pos-
sibly involved in the regulation of bronchial branching mor-
phogenesis as reagents that inhibit fibronectin matrix assem-
bly also caused decreased branching (Roman et al., 1991).
Culture of embryonic lung single cell suspensions in Ma-
trigel, a synthetic BM, can lead to organotypic rearrange-
ment of the cells into structures that closely resemble those
found in vivo, which reinforces the concept that BM is a
major regulator of organogenesis in the lung (Schuger et al.,
1990). These data imply a fundamental role for epithelial–
BM–mesenchymal interactions during lung organogenesis
and airway branching.
Controlled remodeling of the ECM is required for tissue
morphogenesis during development (Vu and Werb, 2000),
and this remodeling is achieved, in part, by the activities of
matrix metalloproteinases (MMPs). Developmental expres-
sion profiles during the second half of mouse gestation have
been documented for only a few MMPs. For example, the
Mmp-2 mRNA is expressed in mesenchymal cells in 14–15
day lung (Reponen et al., 1992) and Mmp-11 is expressed in
lung on Ed14.5 through Ed16.5 in mesenchymal cells lining
the BM (Lefebvre et al., 1995). The Mmp-9 mRNA is
expressed in the primordial alveoli at Ed15 and in the
bronchiole tree on Ed13 and Ed15 (Canete-Soler et al.,
1995), placing the MMP-9 protein in a prime position to
mediate BM thinning associated with bud outgrowth of the
bronchiolar tree. Recent work with mice deficient for the
epidermal growth factor receptor (EGFR) has implicated
MMP-2 along with MMP-14 (MT1-MMP) in the process of
lung branching morphogenesis (Kheradmand et al., 2002).
EGFR null mice demonstrated decreased abundance of
MMP-14 (MT1-MMP) leading to decreased activation of
MMP-2, which, in turn, contributed to impaired branching
observed in the null lungs.
One of the functions of tissue inhibitors of metallopro-
teinases (TIMPs) is to regulate ECM degradation by MMPs.
The expression profiles for Timps-1, -2, and -3 in develop-
ing lung have been previously documented. The Timp-1
mRNA is expressed in lung on Ed15 and Ed17 and in-
creases by Ed18 (Nomura et al., 1989), while Timp-2 is
expressed by mesenchymal tissues surrounding developing
epithelia from Ed10.5 through Ed18.5 (Blavier et al., 1997).
Alternatively, abundant Timp-3 expression is seen in the
developing bronchiole tree at Ed12.5 and Ed14.5, but not in
the mesenchyme. In the newborn mouse, Timp-3 expression
is predominantly in cells of the pulmonary stroma (Apte et
al., 1994). This unique expression pattern in the developing
lung, and the fact that TIMP-3 is the only TIMP family
member known to bind to the ECM (Leco et al., 1994; Yu
et al., 2000), places the TIMP-3 protein in an ideal location
to control the degradation of bronchiole ECM and therefore
possibly contribute to the control of airway branching.
Recently, we developed a mouse line that is deficient for
TIMP-3 (Leco et al., 2001). The TIMP-3 null animals spon-
taneously develop progressive alveolar air space enlarge-
ment similar to that seen in human emphysema, with an
impaired capacity for gas exchange and premature morbid-
ity and mortality. The air space enlargement was observed
as early as 2 weeks of age, which implies a congenital
abnormality in lung development in the TIMP-3 null ani-
mals. We also observed a significant difference between
null and control animals in the distribution of terminal
bronchiole branches relative to the lung pleura, which fur-
ther indicates a role for TIMP-3 in murine lung morpho-
genesis (Leco et al., 2001).
In the present study, we report that the deletion of
TIMP-3 results in decreased bronchiole branching in null
animals beginning as early as Ed12.5 of gestation. The
results indicate that this defect stems from enhanced MMP
activation in the absence of TIMP-3 throughout murine lung
development. The role of MMPs in the defect was corrob-
orated by the inclusion of a synthetic inhibitor of metallo-
proteinases during 48 h of culture of Ed11.5 lung rudiments.
At low dose of inhibitor, branching was augmented in lung
cultures, indicating that substitution of TIMP-3 by a syn-
thetic inhibitor could rescue the defect. Of the BM mole-
cules examined by Western blot analysis, only fibronectin
demonstrated a reduced abundance in the null lungs during
development in vivo. Immunohistochemistry with fibronec-
tin antiserum revealed this reduction of fibronectin was
localised to the BM surrounding bronchioles and in the
stromal ECM and was presumably due to uninhibited MMP
activity. These findings imply an essential role for TIMP-3
in the protection of the ECM from degradation by MMPs
during lung branching morphogenesis and provide further
support of an indispensable function for the ECM in direct-
ing pattern formation throughout lung development.
Materials and methods
Mice
A full description of the generation of the TIMP-3 null
mice used in this study was reported by Leco and coworkers
(2001). For these experiments, the mutant allele was back-
crossed seven generations onto the C57/Black6 strain of
mice for clone seven, and back-crossed six times onto the
C57/Black6 strain of mice for the independently targeted
clone eight. In the last backcross for each line, Timp-3
homozygous null male animals were crossed with wild type
(WT) female C57/Black6 to produce Timp-3 heterozygous
offspring. Non-brother/sister matings then produced both
WT and null animals which were crossed in like genotype,
non-brother/sister matings to produce the WT and null an-
imals used in these studies. In some experiments, where
appropriate, heterozygotic matings produced timed litters
containing all genotypes. The TIMP-3 null line(s) used for
each experiment are identified in legends to figures.
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Timed pregnancies
WT crossed with WT, Timp-3 heterozyogote crossed
with heterozyogote, and Timp-3 null crossed to null mice
were employed for the generation of timed pregnancies with
the day of discovery of a vaginal plug being considered
embryonic day 0.5 (Ed0.5). Tail biopsies were performed on
all litters to provide DNA for PCR genotyping and estab-
lishment of embryonic genotype (not shown). Pregnant
dams were sacrificed at desired time points (Ed11.5 to
Ed17.5), and the embryos were removed and placed into
phosphate-buffered saline (PBS; Life Technologies Inc.,
Burlington, ON, Canada). Newborn animals were sacrificed
at post partum day 1 (PP1). Lungs were removed from the
embryos or pups and then rinsed in fresh PBS. Lungs were
either placed into organ culture, snap frozen on dry ice for
protein analysis, placed in embedding compound (Stephens
Scientific, Riverdale, NJ, USA) and submersed in isopen-
tane cooled on dry ice for fresh frozen sectioning, or fixed
with 4% PBS-buffered paraformaldehyde for 3 h at 4°C,
rinsed in PBS, dehydrated through an alcohol series, and
embedded in paraffin wax for sectioning.
Embryonic lung organ culture
Lung buds were removed from WT, heterozyogote, and
null mouse embryos on Ed11.5 of gestation and placed into
serum-free, BGJb medium supplemented with antibiotic and
antimycotic (Life Technologies Inc.). The lungs were
placed onto culture inserts with 8-m pores using a glass
pipette and cultured at the air-medium interface for 48 h at
37°C and under a 5% CO2 in air atmosphere. Images of
lungs were captured at 0, 24, and 48 h by using a SMZ1500
dissecting microscope, a DXM1200 digital camera, and
ACT-1 software (Nikon Canada, Mississauga, ON,
Canada). For experiments using a synthetic MMP inhibitor,
GM6001 (Chemicon International, Temecula, CA, USA),
lungs were cultured under four conditions: 2.5 M GM6001
in BGJb medium, 20 M GM6001 in BGJb medium or an
equivalent volume of dimethylsulfoxide (DMSO, vehicle
for GM6001) for each of the GM6001 concentrations in
BGJb medium. Use of either volume of DMSO did not
significantly influence lung branching compared to media
alone, and thus DMSO data were pooled.
Quantification of lung bronchiole branching
Extent of peripheral terminal bronchiole branching in
vitro was expressed according to the following equation
(adapted from Schuger et al., 1991):
number of terminal bronchiole buds in null
lung at 48 h number of buds in null lung at 0 h
number of terminal bronchiole buds in WT
lung at 48 h number of buds in WT lung at 0 h
 100.
Images of cultured lungs were digitally captured and the
peripheral terminal buds were counted by two individuals
who were blinded as to the genotype of the lung. A one-way
ANOVA with a Tukey’s post-hoc test was used to deter-
mine the statistical significance between genotypes (Fig. 1),
and a two-way ANOVA with a Tukey’s test was used to
determine the statistical significance in the GM6001 exper-
iments (Fig. 2).
Gelatin zymography
Lung homogenates were obtained from a developmental
series of murine WT and null lungs (Ed13.5–Ed17.5 and
PP1) by grinding frozen lungs in extraction buffer (50 mM
Tris, 150 mM NaCl, 1% SDS plus one EDTA-free protein-
ase inhibitor cocktail pill per 10 ml buffer; Roche Diagnos-
Fig. 1. Impaired bronchiole branching in TIMP-3 null lungs in vitro. (A)
Embryonic day 11.5 (Ed11.5) lungs at time zero of culture (a,c,e); lungs
after 48 h in culture (b,d,f). TIMP-3 null lungs demonstrated impaired
bronchiole branching and dilated terminal buds (f) when compared with
wild type counterparts (b), while heterozyote lungs (d) had an intermediate
number of branches. Scale bar, 200 m. (B) Quantification of the number
of peripheral terminal bronchiole buds after 48 h in culture, expressed as a
percentage of the wild type control (/ SEM). Both heterozyogote and
null lungs showed decreased branching when compared with wild type
lungs; however, only the null lungs showed a significant decrease (one-way
ANOVA; P  0.05). Data for this experiment were collected from both
independently derived clones (clone 7 and clone 8).
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tics, Mannheim, Germany). Protein content of the homog-
enate was determined by the method of Bradford (BioRad
Laboratories Inc., Hercules, CA, USA). Equal amounts of
protein (50 g each) were loaded on a 12% polyacrylamide
gel containing 1 mg/ml gelatin. After electrophoresis, gels
were washed twice for 45 min in 2.5% Triton X-100, rinsed
in water, and incubated in substrate buffer (50 mM Tris, 5
mM CaCl2, 5 M ZnCl2) for 18 h at 37°C. Gels were
stained in Coomassie R350 (BioRad Laboratories Inc.) for
1 h, destained for 20 min, and then allowed to equilibrate in
water overnight.
Gelatin in situ zymography
Gelatin in situ zymography was performed on fresh fro-
zen sections (cut at 7m) as previously described (Leco et
al., 2001). In order to demonstrate that proteolysis was due
to metalloproteinase activity, WT and null tissue sections
were overlayed with substrate containing 5 mM EDTA as a
negative control. Images of experimental sections were cap-
tured after first reducing the exposure time to yield a dark
image with the negative control (EDTA) sections. Once set,
light intensity, exposure time, and the filter used (FITC;
460–500 nm) were identical for all samples. Areas of flu-
orescence are indicative of gelatinolytic activity.
Fig. 2. Inhibition of MMPs effects lung branching morphogenesis in vitro.
(A) Addition of DMSO (vehicle for GM6001) had no effect on lung
cultures, with impaired branching observed in null lungs after 48 h of
culture, as in Fig. 1; wild type (a) versus null (d). Low concentration of
GM6001 (2.5 M) led to an enhanced branching in both wild type (b) and
null lungs (e), while high concentration of GM6001 (20 M) led to
impaired bud formation in both genotypes; wild type (c), null (f). Scale bar,
200 m. (B) Quantification of peripheral terminal lung buds after 48 h in
culture expressed as a percentage of the wild type control (/ SEM).
Treatment of lungs with low concentration of GM6001 led to significantly
increased bronchiole branching (two-way ANOVA; P  0.05) regardless
of genotype. Data for this experiment were collected from both indepen-
dently derived clones (clone 7 and clone 8).
Fig. 3. Zymographic analysis of wild type and null lung tissue homogenate
from Ed13.5 through postpartum day 1 (PP1), inverse images shown. (A)
Increased abundance of a gelatin degrading activity (approximately 55
kDa) was apparent in null lungs throughout development, becoming more
prevalent in later stages (Ed16.5 to PP1). Abundance of latent MMP-9 (105
kDa) was also elevated in null lungs at PP1. (B) Incubation of a sample
lane with GM6001 confirmed that gelatin digestion in all of the bands was
due to metalloproteinase activity. (C) Control conditioned media from baby
hamster kidney cells (BHK CM; source of MMP-2) or conditioned media
from BHK cells transfected with an MMP-9 cDNA (BHK MMP-9 CM)
were compared on a gelatin zymograph to wild type Ed17.5 lung extracts
to distinguish which bands represented MMP-2 and MMP-9. The identity
of the lowest molecular weight band has not been confirmed. Lungs from
clone 8 animals were used in these experiments.
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Fig. 4. Enhanced lung metalloproteinase activity in the absence of TIMP-3. Increased gelatinolytic activity was observed at Ed15.5 by in situ gelatin
zymography in both the mesenchyme and the epithelium surrounding developing bronchioles in TIMP-3 null lungs (d, e; n  10) when compared with wild
type lungs (a, b; n  10). Fluorescence indicates gelatinolytic activity. Incubation of wild type and null lungs with EDTA reduced the fluorescence to
negligible levels confirming that the gelatinolytic activity was due to metalloproteinases (c, f). Scale bar, 50 m. Lungs from clone 8 animals were used in
these experiments.
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Western blot analysis
Western blot analysis was performed on lung homoge-
nates from WT and null lungs (Ed13.5–Ed17.5 and PP1).
Lungs were homogenised in extraction buffer (50 mM Tris,
150 mM NaCl, 1% SDS, 0.1 M -mercaptoethanol plus
one EDTA-free proteinase inhibitor cocktail pill per 10 ml
buffer; Roche Diagnostics), boiled for 3 min, protein con-
tent determined, and 50 g of total protein from each
sample loaded per lane. The samples were electrophoresed
on 4–20% Tris–HCl gradient SDS-PAGE gels (BioRad
Laboratories Inc.). Protein was transferred to nitrocellulose
membranes (Amersham-Pharmacia Biotech, Piscataway,
NJ, USA) and filters were blocked with 5% skim milk in
Tris-buffered saline (TBS). Individual blots were incubated
with antibodies directed against fibronectin (rabbit anti-
mouse polyclonal; 1:5,000 dilution; DAKO Diagnostics
Canada Inc., Mississauga, ON, Canada), collagen type-I
(rabbit anti-mouse polyclonal; 1:1000 dilution; Chemicon
International), laminin (rabbit anti-mouse polyclonal;
1:1000 dilution; DAKO), elastin (rabbit anti-mouse poly-
clonal; 1:1000 dilution; Elastin Products Inc, Owensville,
MO, USA) or glyceraldehyde-3-phosphate dehydrogenase
(GAPDH; mouse monoclonal; 1:10,000 dilution; Cedarlane
Laboratories Limited, Hornby, ON, Canada) diluted in
TBS-T (TBS and 0.1% Tween 20) plus 0.5% skim milk.
After washing in TBS-T, blots were incubated with anti-
mouse or anti-rabbit secondary antibodies conjugated with
horseradish peroxidase (1:5,000 or 1:10,000 dilution for
mouse and rabbit, respectively; Sigma-Aldrich, St. Louis,
MO, USA) diluted in TBS-T plus 0.5% skim milk. After
washing in TBS-T, bands of interest were visualised with
ECL chemiluminescence reagent (Amersham Pharmacia
Biotech) using X-AR film (Eastman Kodak, New Haven,
CT, USA).
Immunohistochemistry
Paraffin-embedded sections from WT and null embry-
onic lungs were cut at 7 m, dewaxed in toluene, and
rehydrated through an alcohol series. After blocking endog-
enous peroxidase activity with 3% H2O2 and antigen re-
trieval by pepsin digestion, sections were incubated with
DAKO blocking solution. Sections were then incubated
with fibronectin antiserum (1:100 dilution in DAKO block-
ing solution) or blocking solution alone (negative control).
After washing in TBS-T, all sections were incubated with
anti-rabbit secondary antibodies conjugated with horserad-
ish peroxidase (1:200 dilution in DAKO blocking solution).
After washing in TBS-T, sections were incubated with AEC
substrate (ICN Biomedicals Inc., Aurora, OH, USA), coun-
terstained with Mayer’s hematoxylin (Sigma), and mounted
under Crystal/Mount (Biomeda Corp., Foster City, CA,
USA). Images were captured by using a Nikon E1000 mi-
croscope as described above.
Results
Impaired bronchiole branching in TIMP-3 null mice
The effect of TIMP-3 deletion on murine bronchiole
branching morphogenesis was first examined in vitro. Em-
bryos were removed from timed pregnant dams on Ed11.5
and lungs placed in organ culture. After 48 h in culture,
bronchiole branching was significantly impaired in the null
lungs (P  0.05), which had 62% of the peripheral terminal
buds when compared with WT lungs. Lungs from heterozy-
gotic pups demonstrated an intermediate number of buds
(Fig. 1A and B). The null terminal buds also had dilated
ends when compared with their WT counterparts (Fig. 1A).
In an attempt to rescue the bronchiole branching defect
seen in the null lungs, a synthetic inhibitor of metallopro-
teinases, GM6001, was added to the organ cultures. Addi-
tion of the vehicle for GM6001 (DMSO) to organ culture
medium had no effect on bronchiole branching in WT or
null lungs (Fig. 2). At the lower concentration of GM6001
(2.5 M), there was significantly enhanced branching (P 
0.05) observed in both the WT and null lungs (150 and
158% of WT controls, respectively; Fig. 2B). When a higher
concentration of GM6001 (20 M) was used, we observed
a decrease in bronchiole branching in the WT lungs (69% of
WT controls; Fig. 2B); however, this result was not deemed
significant.
Enhanced activation of MMPs in the absence of TIMP-3
To examine whether abundance and/or degree of activa-
tion of gelatinolytic MMPs in the developing lung had been
affected by the deletion of TIMP-3, we employed gelatin
zymography. Confirmation of the bands representing
MMP-2 and -9 was achieved by comigration of bands with
those in conditioned media samples from BHK cell cultures
(MMP-2) or BHK cell cultures engineered to overexpress
MMP-9 (Fig. 3C). Confirmation that all bands observed in
the zymographs were metalloproteinases was achieved by
incubation of a lane in the presence of 20 M GM6001
(Fig. 3B).
No consistent difference in levels of latent or active
MMP-2 or -9 was observed between genotypes at any of the
time points examined, with the exception of elevated latent
MMP-9 in newborn null lungs (PP1, Fig. 3A). However, the
null lungs did show increased activity of an unidentified
MMP running at an apparent molecular weight of approx-
imately 55 kDa compared with their WT counterparts
throughout development, with this difference becoming
more apparent in the later stages (Ed16.5 to PP1; Fig. 3A).
Two independently derived lungs for each time point are
represented, and a negative image of the zymography gels is
shown. This experiment was repeated two times with inde-
pendently isolated embryos with similar results (not
shown).
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We next explored how presence or absence of TIMP-3
would impact MMP activity within intact lung tissue using
gelatin in situ zymography (Fig. 4). We observed enhanced
gelatinolytic activity associated with the epithelium of de-
veloping bronchi and throughout the mesenchyme of
TIMP-3 null lungs. Two independently derived Ed15.5
lungs for each genotype are shown. Addition of a metal
chelator (EDTA) to the assay reduced fluorescence to neg-
ligible levels confirming that degradation was due to met-
alloproteinase activity (Fig. 4c and f).
Decreased fibronectin in lungs of TIMP-3 mutant mice
Western blot analysis using antibodies directed against
various ECM components was used to examine whether
there was enhanced ECM degradation resulting from the
deletion of TIMP-3. We examined lung protein extracts
from a developmental series (Ed13.5 to PP1) and found that
there were decreased amounts of fibronectin in the TIMP-3
null lungs throughout development (Fig. 5A). This experi-
ment was repeated three times with independently isolated
embryos with similar results (not shown). Blots were re-
probed for GAPDH as a loading control (Fig. 5B). We also
examined collagen type-1, collagen type-IV, laminin, and
elastin, but were unable to detect differences between
TIMP-3 WT and null lungs at the protein level (not shown).
In order to identify where fibronectin protein abundance
was reduced in vivo, we performed immunohistochemistry
with fibronectin antiserum. Using sections from Ed15.5 and
Ed16.5, we observed reduced fibronectin staining associated
with the terminal ends of bronchiole buds, as well as in cleft
regions of the bronchiole tree in the TIMP-3 null sections
(Fig. 6). Further, overall intensity of fibronectin staining
was reduced throughout the lung mesenchyme (Fig. 6). A
difference was observed at both time points; however, the
reduction was more apparent in the null lung at Ed16.5,
consistent with Western blot analysis.
Defects in bronchiole branching in vivo
We next investigated whether the organ culture pheno-
type resulted from a developmental delay by direct exami-
nation of PP1 null and WT lungs. Branching morphogenesis
normally terminates between the pseudoglandular and can-
nilicular phases of lung development, at around Ed16.5
(Ten Have-Opbroek, 1991). Therefore, we reasoned that
examination of PP1 lungs would allow 2 extra days for the
TIMP-3 null lungs to fully develop if there was a develop-
mental delay. In whole-mount lung preparations, we ob-
served not only fewer bronchioles in equivalent lobes of the
lung, but also that the termini of these bronchioles were
dilated in the null animals (Fig. 7A). Images of eight lungs
for both genotypes were captured and examined, and in all
cases, a consistent observation was made. Examination of
PP1 lungs at the histological level, by hematoxylin and
eosin staining of newborn lung sections, confirmed the
whole-mount observations (Fig. 7B). Further, the degree of
alveolarization was diminished in the null lungs compared
to WT controls. Thus, the defects in branching morphogen-
esis that we observed in the lung organ culture experiments
are not simply due to the culture environment, but are
recapitulated in vivo.
Discussion
The role of the ECM in bronchiole branching morpho-
genesis is well established; however, the mechanisms reg-
ulating its involvement must still be elucidated. One current
model of lung development proposes that a deposition of
ECM components forms clefts which create a mechanical
obstruction restricting the growing lung bud. The lung bud
is then forced to expand around the cleft where there are no
restrictions, thereby forming branches (Ganser et al., 1991;
Mollard and Dziadek, 1998). This model is supported by
evidence showing a thickening of the BM in cleft regions
and a thinning of the BM at the tips of the growing buds.
Further, epithelial cells in the regions of active budding
demonstrate an increased proliferation when compared with
regions of cleft formation (Mollard and Dziadek, 1998).
Remodeling of the ECM is believed to result from a shift
in the balance between activated MMPs and TIMPs (Baker
et al., 2002), and controlled remodeling of the ECM is
required for tissue morphogenesis during development (Vu
and Werb, 2000). As well, proteolytic activity of MMPs has
been implicated in lung branching morphogenesis. For ex-
ample, disruption of a functional EGF receptor impaired
bronchiole branching (Miettinen et al., 1997) by a mecha-
nism subsequently shown to involve the regulation of
Fig. 5. Reduced abundance of fibronectin in the lungs of TIMP-3 null
animals. (A) Western blot analysis of lung tissue homogenate from wild
type or TIMP-3 null lungs demonstrated that null lungs had a decreased
abundance of fibronectin compared with controls throughout development.
Numbers below the fibronectin lanes represent the ratio of wild type lung
fibronectin (set to one for each time point) compared with null lung
fibronectin abundance after normalizing to the signal obtained for the
loading control, GAPDH (B). Lungs from clone 8 animals were used in
these experiments.
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Fig. 6. Fibronectin abundance is decreased in both the basement membrane surrounding bronchiole epithelium and the mesenchymal matrix in the absence
of TIMP-3. Immunohistochemical analysis performed at Ed15.5 demonstrated reduced fibronectin in the basement membranes surrounding the terminal ends
and within the cleft regions of developing bronchioles in the null lungs (d; n  4) when compared with wild type lungs (a; n  4). At Ed16.5, decreased
fibronectin was observed in the bronchiole basement membrane and within the mesenchymal ECM of the null lung (compare b and e; n  4). The negative
control was a wild type Ed16.5 sample incubated without primary antibody (c). Scale bar, 50 m. Lungs from clone 7 animals were used in these experiments.
Fig. 7. Bronchiole branching in the TIMP-3 null lung is reduced in vivo. (A) Whole-mount photomicrographs show that lungs from PP1 null animals (b; n
 8) have impaired branching and dilated terminal buds when compared with lungs from wild type animals (a; n  8). Scale bar, 200 m. (B) Hematoxylin
and eosin staining of PP1 lungs confirm dilation of bronchioles, as well as deficient alveolarization in null lungs. Compare wild type (a, b) with null (c, d);
scale bar, 50 m. Lungs from clone 7 animals were used in these experiments.
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MMP-14-mediated activation of MMP-2 (Kheradmand et
al., 2002). Additionally, lungs deficient for MMP-2 pheno-
copied those of the EGFR null (Kheradmand et al., 2002).
In the present study, we have provided evidence that the
deletion of TIMP-3 results in impaired bronchiole branch-
ing, both in vitro and in vivo, during murine embryogenesis.
In the TIMP-3 null lung, we have shown by gelatin and in
situ zymography that there is enhanced MMP activity,
which may result in inappropriate degradation of fibronectin
in the BM and stroma surrounding the developing bronchi-
ole epithelium. Consistent with this observation, we previ-
ously demonstrated that an unscheduled activation of
MMP-2 correlated with earlier fragmentation of fibronectin
in the involuting mammary gland of TIMP-3-deficient mice
(Fata et al., 2001). Thus, this mechanism of MMP activation
and fibronectin degradation appears to be of importance in
BM breakdown in two distinct branched tissues in the ab-
sence of TIMP-3. We propose that enhanced MMP-medi-
ated degradation of fibronectin in the absence of TIMP-3
leads to decreased cleft formation and thinning of the BM at
the tips of buds, which together results in the decreased
bronchiole branching observed in TIMP-3 null lungs.
The role of MMPs in lung development has also been
explored by using the synthetic metalloproteinase inhibitor,
GM6001. Total inhibition of MMP activity during lung
development in vivo using high concentration of GM6001
resulted in impaired branching (Kheradmand et al., 2002).
In our study, at a low concentration of inhibitor (2.5 M),
we observed a rescue of the TIMP-3 null branching defect
and an augmentation of WT bronchiole branching in vitro.
Taken together, these results imply that total inhibition of
MMP activity results in less branching, possibly due to lack
of BM thinning at the tips of elongating buds, while mod-
erate inhibition of MMP activity could enhance branching
due to a stabilization of clefts. We observed, both in vitro
and in vivo, that heightened MMP activity in the TIMP-3
null lung led to dilation of the terminal buds. These data are
consistent with the work of Ganser and colleagues (1991),
who found that addition of mammalian collagenase to lung
cultures led to impaired branching and enlarged terminal
buds. Thus, MMP activity and subsequent ECM remodeling
during embryonic morphogenetic processes, such as bron-
chiole branching, requires exquisite regulation.
Growth factors and growth factor receptors have been
implicated in bronchiole branching. For example, hepa-
tocyte growth factor (HGF) and the HGF receptor (c-
Met) are expressed by the mesenchyme and epithelium of
the developing lung, respectively, and addition of HGF to
organ culture of fetal lung stimulates branching (Ohmichi
et al., 1998). Further, c-Met can be shed from the cell
surface by an as yet unidentified TIMP-3-sensitive met-
alloproteinase (Nath et al., 2001). We are currently ex-
ploring the hypothesis that, in addition to the loss of
fibronectin from the BM surrounding the developing
bronchiole tree, the reduced branching we see in the null
lungs may result from a disruption in the HGF/c-Met
signaling pathway due to shedding of the c-Met receptor
in the epithelial compartment by the activity of a TIMP-3
sensitive metalloproteinase.
A candidate sheddase for cleavage of c-Met may come
from the class of metalloproteinases known as the ADAMs
(a disintegrin and metalloprotease domain) which are in-
volved in shedding cell surface receptors, a process known
as ectodomain shedding (Black and White, 1998). A recent
study has shown that some ectodomain shedding is required
for normal branching morphogenesis. Lungs deficient for
ADAM-17/TNF- converting enzyme (TACE) have im-
paired branching both in vivo and in vitro (Zhao et al.,
2001). Since TIMP-3 is able to inhibit TACE activity
(Amour et al., 1998), this leads to the expectation that
TACE activity is likely increased in the TIMP-3 null lungs.
Despite this apparent contradiction, subtle modifications of
TACE activity in the TIMP-3 null mice may have pleiotro-
pic effects on ectodomain shedding and therefore tissue
organization during development. Further, TIMP-3 is able
to inhibit many other ADAMs (Amour et al., 2000; Hashi-
moto et al., 2001; Kashiwagi et al., 2001), leaving open the
possibility of enhanced ADAM mediated ectodomain shed-
ding in the TIMP-3 null lungs.
Here, we have provided additional evidence that the
ECM plays an integral role in murine lung branching mor-
phogenesis, involving the dynamic processing of the ECM,
which must not be altered either temporally or spatially. We
have also demonstrated that TIMP-3 has a critical function
in the control of the finely orchestrated ECM degradation
that occurs during lung development. Future experiments
will focus on further defining the precise mechanism(s) by
which TIMP-3 regulates bronchiole branching morphogen-
esis.
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Note added in proof. While this manuscript was being
prepared for publication, Sakai and coworkers reported
that appropriate fibronectin expression is absolutely re-
quired for branching morphogenesis of the salivary gland
(Sakai, T., Larsen, M., Yamada, M., 2003. Fibronectin
requirement in branching morphogenesis. Nature 423,
876 – 881). Our results are consistent with this report, in
that we have also identified fibronectin as a key regulator
of branching morphogenesis in the developing lung.
322 S.E. Gill et al. / Developmental Biology 261 (2003) 313–323
References
Alescio, T., Cassini, A., 1962. Induction in vitro of tracheal buds by
pulmonary mesenchyme grafted on tracheal epithelium. J. Exp. Zool.
150, 83–94.
Amour, A., Slocombe, P.M., Webster, A., Butler, M., Knight, C.G., Smith,
B.J., Stephens, P.E., Shelley, C., Hutton, M., Kna¨uper, V., Docherty,
A.J., Murphy, G., 1998. TNF- converting enzyme (TACE) is inhibited
by TIMP-3. FEBS Lett. 435, 39–44.
Amour, A., Knight, C.G., Webster, A., Slocombe, P.M., Stephens, P.E.,
Kna¨uper, V., Docherty, A.J., Murphy, G., 2000. The in vitro activity of
ADAM-10 is inhibited by TIMP-1 and TIMP-3. FEBS Lett. 473,
275–279.
Apte, S.S., Hayashi, K., Seldin, M.F., Mattei, M.G., Hayashi, M., Olsen,
B.R., 1994. Gene encoding a novel murine tissue inhibitor of metallo-
proteinases (TIMP), TIMP-3, is expressed in developing mouse epi-
thelia, cartilage, and muscle, and is located on mouse chromosome 10.
Dev. Dyn. 200, 177–197.
Baker, A.H., Edwards, D.R., Murphy, G., 2002. Metalloproteinase inhib-
itors: biological actions and therapeutic opportunities. J. Cell Sci. 115,
3719–3727.
Black, R.A., White, J.M., 1998. ADAMs: focus on the protease domain.
Curr. Opin. Cell Biol. 5, 654–659.
Blavier, L., DeClerck, Y.A., 1997. Tissue inhibitor of metalloproteinases-2
is expressed in the interstitial matrix in adult mouse organs and during
embryonic development. Mol. Biol. Cell. 8, 1513–1527.
Canete-Soler, R., Gui, Y.H., Linask, K.K., Muschel, R.J., 1995. Develop-
mental expression of MMP-9 (gelatinase B) mRNA in mouse embryos.
Dev. Dyn. 204, 30–40.
Fata, J.E., Leco, K.J., Voura, E.B., Yu, H.Y., Waterhouse, P., Murphy, G.,
Moorehead, R.A., Khokha, R., 2001. Accelerated apoptosis in the
Timp-3-deficient mammary gland. J. Clin. Invest. 108, 831–841.
Ganser, G.L., Stricklin, G.P., Matrisian, L.M., 1991. EGF and TGF
influence in vitro lung development by the induction of matrix-degrad-
ing metalloproteinases. Int. J. Dev. Biol. 35, 453–461.
Hashimoto, G., Aoki, T., Nakamura, H., Tanzawa, K., Okada, Y., 2001.
Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of met-
alloproteinases (TIMP-1, 2, 3 and 4). FEBS Lett. 494, 192–195.
Kashiwagi, M., Tortorella, M., Nagase, H., Brew, K., 2001. Timp-3 is a
potent inhibitor of aggrecanase 1 (adam-ts4) and aggrecanase 2 (adam-
ts5). J. Biol. Chem. 276, 12501–12504.
Kheradmand, F., Rishi, K., Werb, Z., 2002. Signalling through the EGF
receptor controls lung morphogenesis in part by regulating MT1-MMP-
mediated activation of gelatinase A/MMP2. J. Cell Sci. 115, 839–848.
Leco, K.J., Khokha, R., Pavloff, N., Hawkes, S.P., Edwards, D.R., 1994.
Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular
matrix-associated protein with a distinctive pattern of expression in
mouse cells and tissues. J. Biol. Chem. 269, 9352–9360.
Leco, K.J., Waterhouse, P., Sanchez, O.H., Gowing, K.L.M., Poole, A.R.,
Wakeham, A., Mak, T.W., Khokha, R., 2001. Spontaneous air space
enlargement in the lungs of mice lacking tissue inhibitor of metallo-
proteinase-3 (TIMP-3). J. Clin. Invest. 108, 817–829.
Lefebvre, O., Regnier, C., Chenard, M.P., Wendling, C., Chambon, P.,
Basset, P., Rio, M.C., 1995. Developmental expression of mouse
stromelysin-3 mRNA. Development 121, 947–955.
Miettinen, P.J., Warburton, D., Bu, D., Zhao, J., Berger, J.E., Minoo, P.,
Koivisto, T., Allen, L., Dobbs, L., Werb, Z., Derynck, R., 1997.
Impaired lung branching morphogenesis in the absence of functional
EGF receptor. Dev. Biol. 186, 224–236.
Mollard, R., Dziadek, M., 1998. A correlation between epithelial prolifer-
ation rates, basement membrane component localization patterns, and
morphogenetic potential in the embryonic mouse lung. Am. J. Respir.
Cell Mol. Biol. 19, 71–82.
Nath, D., Williamson, N.J., Jarvis, R., Murphy, G., 2001. Shedding of
c-Met is regulated by crosstalk between a G-protein coupled receptor
and the EGF receptor and is mediated by a TIMP-3 sensitive metallo-
proteinase. J. Cell Sci. 114, 1213–1220.
Nomura, S., Hogan, B.L., Wills, A.J., Heath, J.K., Edwards, D.R., 1989.
Developmental expression of tissue inhibitor of metalloproteinase
(TIMP) RNA. Development 105, 575–583.
Ohmichi, H., Koshimizu, U., Matsumoto, K., Nakamura, T., 1998. Hepa-
tocyte growth factor (HGF) acts as a mesenchyme-derived morpho-
genic factor during fetal lung development. Development 125, 1315–
1324.
Reponen, P., Sahlberg, C., Huhtala, P., Hurskainen, T., Thesleff, I.,
Tryggvason, K., 1992. Molecular cloning of murine 72-kDa type IV
collagenase and its expression during mouse development. J. Biol.
Chem. 267, 7856–7862.
Roman, J., Crouch, E.C., McDonald, J.A., 1991. Reagents that inhibit
fibronectin matrix assembly of cultured cells also inhibit lung branch-
ing morphogenesis in vitro: implications for lung development, injury,
and repair. Chest 99, 20S.
Roman, J., 1997. Fibronectin and fibronectin receptors in lung develop-
ment. Exp. Lung Res. 23, 147–159.
Schuger, L., O’Shea, K.S., Nelson, B.B., Varani, J., 1990. Organotypic
arrangement of mouse embryonic lung cells on a basement membrane
extract: involvement of laminin. Development 110, 1091–1099.
Schuger, L., Skubitz, A.P., O’Shea, K.S., Chang, J.F., Varani, J., 1991.
Identification of laminin domains involved in branching morphogene-
sis: effects of anti-laminin monoclonal antibodies on mouse embryonic
lung development. Dev Biol. 146, 531–541.
Ten Have-Opbroek, A.A., 1991. Lung development in the mouse embryo.
Exp Lung Res. 17, 111–130.
Vu, T.H., Werb, Z., 2000. Matrix metalloproteinases: effectors of devel-
opment and normal physiology. Genes Dev. 14, 2123–2133.
Yu, W.H., Yu, S.C., Meng, Q., Brew, K., Woessner, J.F., 2000. TIMP-3
binds to sulfated glycosaminoglycans of the extracellular matrix.
J. Biol. Chem. 275, 31226–31232.
Zhao, J., Chen, H., Peschon, J.J., Shi, W., Zhang, Y., Frank, S.J., Warbur-
ton, D., 2001. Pulmonary hypoplasia in mice lacking tumor necrosis
factor- converting enzyme indicates an indispensable role for cell
surface protein shedding during embryonic lung branching morphogen-
esis. Dev. Biol. 232, 204–218.
323S.E. Gill et al. / Developmental Biology 261 (2003) 313–323
